No randomised clinical trials have compared peripheral oxygen saturation (SpO2) targets for critically ill children. The harm of interventions to raise SpO2 to > 94% may exceed their benefits. Methods: We undertook an open, parallel-group randomised trial of children > 38 weeks......
In this context, it is important to separate the hazards associated with the use of a device/system and the physiological risks and benefits of the therapy itself. Devices and systems for hypoxia intervention are called "hypoxicators". Hypoxicators fall under the common definition of a medical ...
Nature and Science of Sleep Dovepress open access to scientific and medical research Open Access Full Text Article REVIEW Melatonin's Benefits and Risks as a Therapy for Sleep Disturbances in the Elderly: Current Insights Daniel P Cardinali 1, Gregory M Brown2, Seithikurippu R Pandi-Perumal 3 ...
Pediatric Health, Medicine and Therapeutics Dovepress open access to scientific and medical research Open Access Full Text Article Assessing the benefits and risks of tight glycemic control in critically ill children Review This article was published in the following Dove Press journal: Pediatric Health...
View benefits and risks of Avastin® (bevacizumab) treatment for metastatic colorectal cancer (mCRC). See full safety for more information.
A pericardiocentesis is a treatment that is performed to address fluid buildup in the pericardium. Get more information about the risks and benefits.
To review the cerebrovascular pathophysiology of hypertension, and the risks and benefits of antihypertensive therapies in the patient with intracranial ischemic or space-occupying pathology. Review of English language scientific and clinical literature, using MEDLINE search. Pertinent literature is referenced...
Nanotechnology holds immense promise in revolutionising healthcare, offering unprecedented opportunities in diagnostics, drug delivery, cancer therapy, and combating infectious diseases. This review explores the multifaceted landscape of nanotechnology in healthcare while addressing the critical aspects of safety...
Future work will need to investigate the risk of not only using mTORi, but provide data on the risk/benefits of stopping and starting the drug in pregnancy. It is not surprising that 71.6% (n = 53) of providers do not have established provider/clinic protocols to guide pregnancy care...
In this episode, I discuss methylenedioxymethamphetamine (MDMA), which is also commonly known as “ecstasy” or “molly,” including how it works in the brain to cause short- and long- term-shifts in emotional processing and its clinical applicat